Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report)'s stock price gapped up prior to trading on Thursday . The stock had previously closed at $17.04, but opened at $17.50. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $18.49, with a volume of 3,960 shares.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on TLX shares. Wedbush reissued an "outperform" rating and issued a $22.00 price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Thursday. William Blair reissued an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.
Check Out Our Latest Report on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Stock Up 2.5%
The company's fifty day simple moving average is $16.93 and its 200-day simple moving average is $16.90.
Hedge Funds Weigh In On Telix Pharmaceuticals Limited American Depositary Shares
An institutional investor recently bought a new position in Telix Pharmaceuticals Limited American Depositary Shares stock. ABC Arbitrage SA purchased a new position in Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 26,939 shares of the company's stock, valued at approximately $451,000.
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
(
Get Free Report)
Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Further Reading
Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.
While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
